Workflow
之江生物: 之江生物:关于2025年第二次股份回购实施结果的公告

Core Viewpoint - The company has successfully completed its second share repurchase plan for 2025, aimed at maintaining company value and protecting shareholder interests, with a total repurchase amount of approximately 110 million RMB [1][2][3]. Summary by Sections Repurchase Plan Details - The repurchase plan was first disclosed on April 30, 2025, with an implementation period from April 28, 2025, to July 25, 2025 [1]. - The expected repurchase amount ranges from 60 million RMB to 120 million RMB, with a maximum repurchase price set at 25.05 RMB per share [1]. - The repurchased shares are intended for maintaining company value and shareholder rights, and may also be used for employee stock ownership plans or convertible bond conversions [1]. Implementation Status - As of the announcement date, the company has repurchased a total of 5,829,475 shares, representing 3.03% of the total share capital of 192,157,999 shares [2][3]. - The repurchase was conducted at a price range of 16.50 RMB to 23.69 RMB per share, with an average price of 18.87 RMB per share, totaling approximately 110 million RMB [2][3]. Financial Impact - The funds used for the repurchase include self-owned funds and a special loan from a bank, which will not significantly impact the company's operational activities, financial status, or future development [3]. - The completion of the share repurchase will not lead to any changes in company control or affect its listing status [3]. Shareholder Transactions - During the repurchase period, there were no stock transactions by the company's directors, supervisors, senior management, controlling shareholders, or actual controllers [4]. Share Changes and Future Plans - Before the repurchase, the total number of shares was 192,157,999, and after the repurchase, the number of shares held in the repurchase account increased from 8,808,833 to 14,638,308 [4]. - The repurchased shares will be sold through centralized bidding within 12 months after the announcement of the repurchase results, and if not sold within three years, the unsold shares will be canceled [5].